Jane A. Thanassi
Alexion Pharma (Switzerland)(CH)
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Complement system in diseases, Antibiotic Resistance in Bacteria, Antimicrobial Resistance in Staphylococcus, Blood groups and transfusion
Most-Cited Works
- → Identification of 113 conserved essential genes using a high-throughput gene disruption system in Streptococcus pneumoniae(2002)231 cited
- → Dissemination among staphylococci of DNA sequences associated with methicillin resistance(1994)151 cited
- → Role of mecA transcriptional regulation in the phenotypic expression of methicillin resistance in Staphylococcus aureus(1996)113 cited
- → Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome(2016)98 cited
- → Characterization of IS1272, an insertion sequence-like element from Staphylococcus haemolyticus(1996)69 cited
- → Staphylococcus haemolyticus contains two D-glutamic acid biosynthetic activities, a glutamate racemase and a D-amino acid transaminase(1995)62 cited
- → Identification and characterization of cell wall-cell division gene clusters in pathogenic gram-positive cocci(1997)60 cited
- → Selenophene-Containing Inhibitors of Type IIA Bacterial Topoisomerases(2011)55 cited
- → In Vitro and In Vivo Profiles of ACH-702, an Isothiazoloquinolone, against Bacterial Pathogens(2011)54 cited
- → Isothiazoloquinolones with Enhanced Antistaphylococcal Activities against Multidrug-Resistant Strains: Effects of Structural Modifications at the 6-, 7-, and 8-Positions(2006)52 cited